🔥🐔 BizChicken 🐔🔥
Learn About the Corporations Around You
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Cingulate Inc.
Market Cap: Lowest
Employees: Lowest
CTx-1301
Cingulate Inc. is focused on developing product candidates for treating attention-deficit/hyperactivity disorder (ADHD) and anxiety disorders. Its pipeline includes CTx-1301 and CTx-1302 for ADHD, and CTx-2103 for anxiety.
Website
About | Management | Directors | About | About | Contact | Contact | Careers | About | About | About
Symbol: CING
Recent Price: $4.98
Industry: Biotechnology
CEO: Dr. Shane J. Schaffer Pharm.D.
Sector: Healthcare
Employees: 13
Address: 1901 West 47th Place, Kansas City, KS 66205
Phone: 913 942 2300
Leadership
- Shane J. Schaffer, PharmD, Chairman, Chief Executive Officer
- Peter J. Werth, Director
- Jeff Ervin, Director
- Bryan Lawrence, Director
- Jay Roberts, Director
Last updated: 2024-12-31